Benign ovarian cysts and ovarian cancer: A cohort study with implications for screening

Lancet

Volumn 355, Issue 9209, 2000, Pages 1060-1063

  Crayford, Timothy J B ^a   Campbell, Stuart ^b   Bourne, Thomas H ^b   Rawson, Helen J ^a   Collins, William P ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER MORTALITY; CANCER SCREENING; CANCER STAGING; COHORT ANALYSIS; COLORECTAL CANCER; FEMALE; FOLLOW UP; HUMAN; LIFE TABLE; LUNG CANCER; MAJOR CLINICAL STUDY; OVARY CANCER; OVARY CYST; OVARY TUMOR; PRIORITY JOURNAL;

EID: 0034712543     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)02038-9     Document Type: Article

References (26)

1. Petterson F. Annual FIGO Report on the results of treatment in gynecological cancer, volume 22. Stockholm: Repro Print, 1995: 83-102.
2. Parker S.L., Tong T., Bolden S., Wingo P.A. Cancer statistics, 1996. Cancer J Clin. 65:1996;5-27.
3. Collins W.P., Bourne T.H., Campbell S. Screening strategies for ovarian cancer. Curr Opin Obstet Gynecol. 10:1998;33-39.
4. Anderson M.C. Malignant potential of benign ovarian cysts: the case for. Sharp F., Mason W.P., Leake R.E. Ovarian cancer: biological and therapeutic challenges. 1990;187-190 Chapman and Hall Medical, London.
5. Scully R.E. Early ovarian cancer. Sharp F., Mason W.P., Creaseman W. Ovarian cancer 2: biology, diagnosis and management. 1992;199-205 Chapman and Hall Medical, London.
6. Bell D.A., Scully R.E. Early de novo ovarian carcinoma. a study of fourteen cases Cancer. 73:1994;1859-1864.
7. Scully R.E. Pathology of ovarian cancer precursors. J Clin Biochem Suppl. 23:1995;208-218.
8. Salazar H., Godwin A.K., Daly M.B.et al. Microscopic benign and invasive malignant neoplasms and a cancer prone phenotype in prophylactic oophorectomies. J Natl Cancer Inst. 88:1996;1810-1820.
9. Hoskins W.J. Histologic changes in the ovaries of cancer prone women: an indication of premalignant change? J Natl Cancer Inst. 88:1996;1790-1791.
10. Scully R.E., Bell D., Abu-Jawdeh G. Update on early ovarian cancer and cancer developing in benign ovarian tumors. Sharp F., Mason P., Blackett T., Berek J. Ovarian cancer 3. 1995;139-144 Chapman & Hall, London.
11. Scully R.E. Early de novo ovarian cancer and cancer developing in benign ovarian lesions. Int J Gynaecol Obstet. 49:1995;s9-15. (suppl).
12. Bhan V., Amso N., Whitehead M.I., Campbell S., Royston P., Collins W.P. Characteristics of persistent masses as asymptomatic women. Br J Obstet Gynaecol. 96:1989;1384-1391.
13. Bourne T.H., Whitehead M.I., Campbell S., Royston P., Bhan V., Collins W.P. Ultrasound screening for familial ovarian cancer. Gynecol Oncol. 43:1991;92-97.
14. Powell D.E., Puls L., van Nagell J. Jr. Current concepts in epithelial ovarian tumors: does benign to malignant transformation occur? Hum Path. 23:1992;846-847.
15. Poels L.E., Powell D.e., DePriest P.D.et al. Transition from benign to malignant epithelium in mucinous and serous ovarian cystadenocarcinoma. Gynecol Oncol. 47:1992;53-57.
16. Zheng J., Wan M., Zweizig S., Velicescu M., Yu M.C., Dubeau L. Histologically benign or low grade tumors adjacent to high-grade ovarian carcinomas contain molecular characteristics of high-grade carcinomas. Cancer Res. 53:1993;4138-4142.
17. Campbell S., Goessens L., Goswamy R., Whitehead M.I. Real-time ultrasonography for determination of ovarian morphology and volume: a possible early screening test for ovarian cancer. Lancet. i:1982;425-426.
18. Goswamy R.K., Campbell S., Whitehead M.I. Screening for ovarian cancer. Clin Obstet Gynaecol. 10:1983;621-643.
19. Health Survey for England 1982. 1982;H M Stationery Office, London.
20. Twentieth Century Mortality CD-ROM. 1998;Office of National Statistics, London.
21. Breslow N.E., Day N.E. The design and analysis of cohort studies. Statistical methods in cancer research II. 1987;WHO/IARC Publications, Lyon.
22. Westhoff C., Clark C.J. Benign ovarian cysts in England and Wales and in the United States. Br J Obstet Gynaecol. 99:1992;329-332.
23. Bailey C.L., Ueland F.R., Land G.L.et al. The malignant potential of small cystic ovarian tumours in women over 50 years of age. Gynecol Oncol. 69:1998;3-7.
24. Campbell S., Royston P., Bhan V., Whitehead M.I., Collins W.P. Novel screening strategies for early ovarian cancer by transabdominal ultrasonography. Br J Obstet Gynaecol. 97:1990;304-311.
25. Tailor A., Jurkovic D., Bourne T.H., Collins W.P., Campbell S. Sonographic prediction of malignancy in adnexal masses using multivariate logistic regression analysis. Ultrasound Obstet Gynecol. 10:1997;41-47.
26. Timmerman D., Verrelst H., Bourne T., Moreau Y., Collins W.P., Vergote I. Artificial neural network models for the preoperative discrimination between benign and malignant adnexal masses. Ultrasound Obstet Gynecol. 13:1999;17-25.